Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Imfinzi approved in the EU for the treatment of extensive-stage small cell lung cancer
-
Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups
-
AstraZeneca’s scientific and social commitment for COVID-19 vaccine
-
Farxiga demonstrated unprecedented reduction in the risk of kidney failure and cardiovascular or renal death in patients with chronic kidney disease in the Phase III DAPA-CKD trial
-
Farxiga Phase III DAPA-CKD trial paradigm-shifting data to be presented at ESC 2020
-
Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
-
Imfinzi approved in Japan for the treatment of extensive-stage small cell lung cancer
-
Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use
-
AstraZeneca concludes agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine
-
Nirsevimab reduced respiratory syncytial virus infections and hospitalisations in preterm infants in Phase IIb trial
Latest articles and press releases
All of our latest press releases and articles are available to explore
